The AgI/II Family Adhesin AspA Is Required for Respiratory Infection by Streptococcus pyogenes

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Franklin, Linda ^a,b   Nobbs, Angela H ^b   Bricio Moreno, Laura ^c   Wright, Christopher J ^b   Maddocks, Sarah E ^b   Sahota, Jaspreet Singh ^a   Ralph, Joe ^a   O'Connor, Matthew ^a   Jenkinson, Howard F ^b   Kadioglu, Aras ^a,c  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; PROTEIN ASPA; UNCLASSIFIED DRUG; ADHESIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPA GENE; BACTERIAL COLONIZATION; BACTERIAL GENE; CELL KILLING; CELL PHAGOCYTOSIS; CONTROLLED STUDY; FEMALE; GENE DELETION; GROUP A STREPTOCOCCAL INFECTION; IN VITRO STUDY; IN VIVO STUDY; LOWER RESPIRATORY TRACT INFECTION; MICROBIAL ADHESION; MOUSE; NONHUMAN; RESPIRATORY EPITHELIUM; RESPIRATORY TRACT INFECTION; RHINOPHARYNGITIS; ANIMAL; BACTERIUM ADHERENCE; CELL LINE; GENETICS; HOST PATHOGEN INTERACTION; HUMAN; IMMUNOLOGY; MICROBIOLOGY; NASOPHARYNX; PATHOGENICITY; PHAGOCYTOSIS; PHYSIOLOGY; RESPIRATORY SYSTEM; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PYOGENES;

LACTOCOCCUS LACTIS; STREPTOCOCCUS PYOGENES;

ADHESINS, BACTERIAL; ANIMALS; BACTERIAL ADHESION; CELL LINE; FEMALE; GENE DELETION; HOST-PATHOGEN INTERACTIONS; HUMANS; MICE; NASOPHARYNX; PHAGOCYTOSIS; RESPIRATORY SYSTEM; RESPIRATORY TRACT INFECTIONS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES;

EID: 84876954459     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0062433     Document Type: Article

References (52)

1. Bessen DE, (2009) Population biology of the human restricted pathogen, Streptococcus pyogenes. Infect Genet Evol 9: 581-93.
2. Bessen DE, Manoharan A, Luo F, Wertz JE, Robinson DA, (2005) Evolution of transcription regulatory genes is linked to niche specialization in the bacterial pathogen Streptococcus pyogenes. J Bacteriol 187: 4163-72.
3. Conley J, Olson ME, Cook LS, Ceri H, Phan V, et al. (2003) Biofilm formation by group A streptococci: is there a relationship with treatment failure? J Clin Microbiol 41: 4043-8.
4. Steer AC, Law I, Matatolu L, Beall BW, Carapetis JR, (2009) Global emm type distribution of group A streptococci: systematic review and implications for vaccine development. Lancet Infect Dis 9: 611-6.
5. Olsen RJ, Shelburne SA, Musser JM, (2009) Molecular mechanisms underlying group A streptococcal pathogenesis. Cell Microbiol 11: 1-12.
6. Eliasson M, Frick IM, Collin M, Sørensen OE, Bjørck L, et al. (2007) MI protein of Streptococcus pyogenes increases production of the antibacterial CXC chemokine MIG/CXCL9 in pharyngeal epithelial cells. Microb Pathog 43: 224-33.
7. Kreikemeyer B, Oehmcke S, Nakata M, Hoffrogge R, Podbielski A, (2004) Streptococcus pyogenes fibronectin-binding protein F2: expression profile, binding characteristics, and impact on eukaryotic cell interactions. J Biol Chem 279: 15850-9.
8. Hyland KA, Wang B, Cleary PP, (2007) Protein F1 and Streptococcus pyogenes resistance to phagocytosis. Infect Immun 75: 3188-91.
9. Nobbs AH, Lamont RJ, Jenkinson HF, (2009) Streptococcus adherence and colonization. Microbiol Mol Biol Rev 73: 407-50.
10. Manetti AG, Zingaretti C, Falugi F, (2007) Streptococcus pyogenes pili promote pharyngeal cell adhesion and biofilm formation. Mol Microbiol 64: 968-83.
11. Green NM, Zhang S, Porcella SF, (2005) Genome sequence of a serotype M28 strain of group A Streptococcus: potential new insights into puerperal sepsis and bacterial disease specificity. J Infect Dis 192: 760-70.
12. Sitkiewicz I, Green NM, Guo N, Mereghetti L, Musser JM, (2011) Lateral gene transfer of streptococcal ICE element RD2 (region of difference 2) encoding secreted proteins. BMC Microbiol 11: 65.
13. Colman G, Tanna A, Estratiou A, Gaworzewska ET, (1993) The serotypes of Streptococcus pyogenes present in Britain during 1980-1990 and their association with disease. J Med Microbiol 39: 165-78.
14. Areschoug T, Carlsson F, Stålhammar-Carlemalm M, Lindahl G, (2004) Host-pathogen interactions in Streptococcus pyogenes infections, with special reference to puerperal fever and a comment on vaccine development. Vaccine 22Suppl 1: S9-14.
15. Stålhammar-Carlemalm M, Areschoug T, Larsson C, Lindahl G, (1999) The R28 protein of Streptococcus pyogenes is related to several group B streptococcal surface proteins, confers protective immunity and promotes binding to human epithelial cells. Mol Microbiol 33: 208-19.
16. Zhang S, Green NM, Sitkiewicz I, Lefebvre RB, Musser JM, (2006) Identification and characterization of an antigen I/II family protein produced by group A Streptococcus. Infect Immun 74: 4200-13.
17. Maddocks SE, Wright CJ, Nobbs AH, (2011) Streptococcus pyogenes antigen I/II-family polypeptide AspA shows differential ligand-binding properties and mediates biofilm formation. Mol Microbiol 81: 1034-49.
18. Brady LJ, Maddocks SE, Larson MR, Forsgren N, Persson K, et al. (2010) The changing faces of Streptococcus antigen I/II polypeptide family adhesins. Mol Microbiol 77: 276-86.
19. Lee SF, Progulske-Fox A, Erdos GW, Piacentini DA, Ayakawa GY, et al. (1989) Construction and characterization of isogenic mutants of Streptococcus mutans deficient in major surface protein antigen P1 (I/II). Infect Immun 57: 3306-13.
20. Jakubovics NS, Strömberg N, van Dolleweerd CJ, Kelly CG, Jenkinson HF, (2005) Differential binding specificities of oral streptococcal antigen I/II family adhesins for human or bacterial ligands. Mol Microbio 55: 1591-605.
21. Lamont RJ, El-Sabaeny A, Park Y, Cook GS, Costerton JW, et al. (2002) Role of Streptococcus gordonii SspB protein in the development of Porphyromonas gingivalis biofilms on streptococcal substrates. Microbiolog 148: 1627-36.
22. Nobbs AH, Shearer BH, Drobni M, Jepson MA, Jenkinson HF, (2007) Adherence and internalization of Streptococcus gordonii by epithelial cells involves β1 integrin recognition by SspA and SspB (antigen I/II family) polypeptides. Cell Microbiol 9: 65-83.
23. Cleary PP, Matsuka YV, Huynh T, Lam H, Olmsted SB, (2004) Immunization with C5a peptidase from either group A or group B streptococci enhances clearance of group A streptococci from intranasally infected mice. Vaccine 22: 4332-41.
24. Mannam P, Jones KF, Geller BL, (2004) Mucosal vaccine made from live, recombinant Lactococcus lactis protects mice against pharyngeal infection with Streptococcus pyogenes. Infect Immun 72: 3444-50.
25. Hyland KA, Brennan R, Olmsted SB, Rojas E, Murphy E, et al. (2009) The early interferon response of nasal-associated lymphoid tissue to Streptococcus pyogenes infection. FEMS Immunol Med Microbiol 55: 422-31.
26. Johnson DR, Kurlan R, Leckman J, Kaplan EL, (2010) The human immune response to streptococcal extracellular antigens: clinical, diagnostic, and potential pathogenic implications. Clin Infect Dis 50: 481-90.
27. Kadioglu A, Taylor S, Iannelli F, Pozziu G, Mitchell TJ, et al. (2002) Upper and lower respiratory tract infection by Streptococcus pneumoniae is affected by pneumolysin deficiency and differences in capsule type. Infect Immun 70: 2886-90.
28. Manco S, Hernon F, Yesikaya H, Paton JC, Andrew PW, et al. (2006) Pneumococcal neuraminidases A and B both have essential roles during infection of the respiratory tract and sepsis. Infect Immun 74: 4014-20.
29. Romero-Steiner S, Frasch C, Concepcion N, (2003) Multilaboratory evaluation of a viability assay for measurement of opsonophagocytic antibodies specific to the capsular polysaccharides of Streptococcus pneumoniae. Clin Diagn Lab Immunol 10: 1019-24.
30. Bangert M, Bricio-Moreno L, Gore S, Rajam G, Ades EW, et al. (2012) P4-mediated antibody therapy in an acute model of invasive pneumococcal disease. J Infect Dis 205: 1399-407.
31. Lam J, Herant M, Dembo M, Heinrich V, (2009) Baseline mechanical characterization of J774 macrophages. Biophys J 96: 248-54.
32. Richards L, Ferreira DM, Miyaji EN, Andrew PW, Kadioglu A, (2010) The immunising effect of pneumococcal nasopharyngeal colonisation; protection against future colonisation and fatal invasive disease. Immunobiology 215: 251-63.
33. Dale JB, Washburn RG, Margues MB, Wessels MR, (1996) Hyaluronate capsule and surface M protein in resistance to opsonisation of group A streptococci. Infect Immun 64: 1495-501.
34. Cole JN, Barnett TC, Nizet V, Walker MJ, (2011) Molecular insight into invasive group A streptococcal disease. Nat Rev Microbiol 16 9(10): 724-36.
35. Liang Z, Zhang Y, Agrahari G, Chandrahas V, Glinton K, et al. (2013) A Natural Inactivating Mutation in the CovS Component of the CovRS Regulatory Operon in a Pattern D Streptococcal pyogenes Strain Influences Virulence-associated Genes. J Biol Chem 288(9): 6561-73.
36. Tran-Winkler HJ, Love JF, Gryllos I, Wessels MR, (2011) Signal transduction through CsrRS confers an invasive phenotype in group A Streptococcus. Plos Pathog 7(10): e1002361.
37. Hollands A, Pence MA, Timmer AM, Osvath SR, Turnbull L, et al. (2010) Genetic switch to hypervirulence reduces colonization phenotypes of the globally disseminated group A streptococcus M1T1 clone. J Infect Dis 1 202(1): 11-9.
38. Poirier TP, Kehoe MA, Whitnack E, Dockter ME, Beachey EH, (1989) Fibrinogen binding and resistance to phagocytosis of Streptococcus sanguis expressing cloned M protein of Streptococcus pyogenes. Infect Immun 57: 29-35.
39. Berggård K, Johnsson E, Morfeldt E, Persson J, Stålhammar-Carlemalm, et al, (2001) Binding of human C4BP to the hypervariable regions of M protein: a molecular mechanism of phagocytosis resistance in Streptococus pyogenes. Mol Microbiol 42: 539-551.
40. Carlsson F, Sandin C, Lindahl G, (2005) Human fibrinogen bound to Streptococcus pyogenes M protein inhibits complement deposition via the classical pathway. Mol Microbiol 56: 28-39.
41. Courtney HS, Hasty DL, Dale JB, (2006) Anti-phagocytic mechanisms of Streptococcus pyogenes: binding of fibrinogen to M-related protein. Mol Microbiol 59: 936-47.
42. Kihlberg BM, Collin M, Olsén A, Björck L, (1999) Protein H, an antiphagocytic surface protein in Streptococcus pyogenes. Infect Immun 67: 1708-14.
43. Ji Y, Schnitzler N, DeMaster E, Cleary P, (1998) Impact of M49, Mrp, Enn, and C5a peptidase proteins on colonization of the mouse oral mucosa by Streptococcus pyogenes. Infect Immun 66: 5399-405.
44. Collin M, Svensson MD, Sjöholm AG, Jensenius JC, Sjöbring U, et al. (2002) EndoS and SpeB from Streptococcus pyogenes inhibit immunoglobulin-mediated opsonophagocytosis. Infect Immun 70: 6646-51.
45. Sjögren J, Okumura CY, Collin M, Nizet V, Hollands A, (2011) Study of the IgG endoglycosidase EndoS in group A streptococcal phagocyte resistance and virulence. BMC Microbiol 11: 120.
46. Kuo CF, Lin YS, Chuang WJ, Wu JJ, Tsao N, (2008) Degradation of complement 3 by streptococcal pyrogenic exotoxin B inhibits complement activation and neutrophil opsonophagocytosis. Infect Immun 76: 1163-9.
47. Terao Y, Mori Y, Yamaguchi M, Shimizu Y, Ooe K, et al. (2008) Group A streptococcal cysteine protease degrades C3 (C3b) and contributes to evasion of innate immunity. J Biol Chem 283: 6253-60.
48. Caswell CC, Han R, Hovis KM, Ciborowski P, Keene DR, et al. (2008) The Scl1 protein of Mg-type group A Streptococcus binds the human complement regulatory protein, factor H, and inhibits the alternative pathway of complement. Mol Microbio 67: 584-96.
49. Terao Y, Yamaguchi M, Hamada S, Kawabata S, (2006) Multifunctional glyceraldehyde-3-phosphate dehydrogenase of Streptococcus pyogenes is essential for evasion from neutrophils. J Biol Chem 281: 14215-23.
50. Lei B, Liu M, Meyers EG, Manning HM, Nagiec MJ, et al. (2003) Histidine and aspartic acid residues important for immunoglobulin G endopeptidase activity of the group A Streptococcus opsonophagocytosis-inhibiting Mac protein. Infect Immun 71: 2881-4.
51. Agniswamy J, Lei B, Musser JM, Sun PD, (2004) Insight of host immune evasion mediated by two variants of group A Streptococcus Mac protein. J Biol Chem 279: 52789-96.
52. Kwinn LA, Nizet V, (2007) How group A Streptococcus circumvents host phagocytic defences. Future Microbiol 2: 75-84.